Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies

NCT02485717 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

291

Enrollment

INDUSTRY

Sponsor class

Conditions

Scabies

Interventions

DRUG: spinosad topical suspension, 0.9%
OTHER: Placebo

Sponsor

ParaPRO LLC

Collaborators

[object Object]